A STUDY ON KNOWLEDGE, ATTITUDE AND PRACTICE OF PHARMACOVIGILANCE TOWARDS ADR REPORTING AMONG JUNIOR RESIDENT, SENIOR RESIDENT AND CONSULTANT DOCTORS IN TERTIARY CARE SETTING OF TEACHING MEDICAL INSTITUTION
KAP study on Pharmacovigilance towards ADR among Health Professional at Tertiary Health Care Setting
Keywords:
Adverse Drug Reaction; Pharmacovigilance; Health care professionalsAbstract
Objective: In order to improve the ADR reporting rate. This study was undertaken to evaluate KAP of the health care professionals at a Tertiary Care teaching hospital, regarding the ADR monitoring and pharmacovigilance.
Methods: This cross-sectional study was conducted in a tertiary health care setting of State Medical College of U.P. Health professionals such as Junior Residents, Senior Residents and consultants were participated in the study. Knowledge about ADR, attitudes towards ADR, the voluntary reporting system, procedures related & reasons for non-reporting, etc was assessed. Data was collected and analyzed by applying appropriate software.
Results: Most of the participants (62.4%) felt that PVs report should be made mandatory. Majority of Junior Residents knew the theoretical definition and purpose of PVs comparatively more than SR and consultants. Responses showing attitude of the study participant’s towards pharmacovigilance depicts that most of the participants (62.4%) felt that PVs report should be made mandatory. Practical aspects of ADRs by different cadres of participant viz. consultants (68.0%), SR (50%) and JR (35.7%) were found to be statistically significant; p=.037. Factors which discourage health professional from reporting ADRs viz. Non-remuneration, Lack of time, Single case not affect ADR database or Difficulty in decision whether ADR has occurred or not.
Conclusion: Only few of the health professional (20%) were ever reported an ADR but still there is great need to create awareness among the Junior/ Senior doctors/Consultants to improve the reporting of ADRs. An educational intervention and improvement of facilities in coordinating with the healthcare professionals would definitely bring on a difference in adverse drug reactions.
Downloads
References
Rubina Mulchandania R, Kakkarb AK. Reporting of adverse drug reactions in India: a review of the current scenario, obstacles and possible solutions. Int J Risk Safe Med 2019;30(1):33–34. DOI: 10.3233/ JRS-180025.
World Health Organization, Pharmacovigilance. Available a: https:// www.who.int/medicines/areas/quality_safety/safety_efficacy/ pharmvigi/en/ Accessed on: 22 April 2024.
Sahu S, Rishishwar P, Rathod C. Pharmacovigilance practice for safety of medication system in India. J Phytopharmaco 2018;7:216–221.
National Humam Genome Research Institute, Pharmacogenomics FAQ. Available at: https://www.genome.gov/FAQ/Pharmacogenomics Accessed on 22 April 2024.
Gupte N, Pradhan S. Pharmacovigilance: Perspectives in India. J Med Acad 2020;3(2):59–62.
Health Professionals’ Knowledge, attitudes and practices about Pharmacovigilance in India: A systematicreview and meta-analysis. Available at:: http://journals.plos.org/plosone/ Accessed on: 25 April 2024.
Srinivasan V, Sheela D, Mridula D. Knowledge, attitude, and practice of pharmacovigilance among the healthcare professionals in a tertiary care hospital – A questionnaire study. Biomed Pharmacol J 2017; 10(3). Available at http://biomedpharmajournal.org/?p=16563. Accessed on: 25 April 2024.
Gupta P, Udupa A. 2011. Adverse Drug Reaction Reporting and Pharmacovigilance: Knowledge, Attitudes and Perceptions amongst Resident Doctors. Journal of Pharmaceutical Sciences and Research, 3(2):1064-1069.
Jagminder H, Bajaj K, Kumar R. 2013. A survey on the knowledge, attitude and the practice of pharmacovigilance among the health care professionals in a teaching hospital in northern India. Journal of Clinical and Diagnostic Research,7(1): 97-99 .
Mohapatra S. , Althab Begum M. , Sashwath Srikanth , R. Jamuna Rani.2019. Knowledge, attitude and the practice (KAP) of Pharmacovigilance among health care professionals of a tertiary care teaching hospital of South India. Asian Journal of Pharmacy and Pharmacology 2019; 5(4):669-672 .
Qing L, Su-min Z, Hua-ting C, Shi-ping F, Xin Y, Dong L. 2004.The awareness and the attitudes of the healthcareprofessionals in Wuhan, China about/towards thereporting of adverse drug reac- tions. Chinese MedicalJournal, 117(6): 856-61.
Belton KJ, Lewis SC, Payne S, Rawlins MD, Wood SM 1995. Anattitudinal survey on the adverse drug reaction reporting bythe medical practitioners in the United Kingdom. BritishJournal of Clinical Pharmacology, 39(3): 223–26.
Bateman DN, Sanders GLS, Rawlins MD. 1992. The attitudes to the ad- verse drug reaction reporting in the northern region. British Journal of Clinical Pharmacology, 34(5): 421–26.
Tabali M, Jeschke E, Bockelbrink A, Witt CM, Willich S N,Ostermann T, Matthes H. 2009. An educational intervention to improve the physician reporting of the adverse drug reactions (ADRs) in a primary care setting in the complementary and alternative medicine programs. BMC Public Health, 9:274.
Published
How to Cite
Issue
Section
Copyright (c) 2024 SOM NATH, Dr Deepak, MANJUSHA
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.